Article Name North America
40-Hz DIFS™ significantly improves cognitive performance and brain connectivity in peer-reviewed clinical trial
09th October, 2025
Ion, Intuitive’s robotic-assisted bronchoscopy platform, features an ultra-thin, shape-sensing catheter designed to navigate deep into the lung
09th October, 2025
New gene expression profiling test enhances precision in assessing lung transplant rejection and injury
09th October, 2025
The FDA's Breakthrough Devices Program is intended to expedite the development and FDA review of medical devices granted BDD
08th October, 2025
First-in-human cases lay the foundation for the next frontier in robotic microsurgery
07th October, 2025
Basil’s AI-powered Safety Signaling helps manufacturers identify risks associated with recalls, accelerate corrective actions, and strengthen patient safety
07th October, 2025
Early Commercial Launch Demonstrates Strong Physician Demand, Successful Pre-Authorisations, and Widespread Payor Coverage
06th October, 2025
The company completed a human factors validation study at Johns Hopkins Hospital
03rd October, 2025
Designed for Freedom, the newly FDA-cleared system will be showcased at RSNA
30th September, 2025
The newly issued patent strengthens Nexalin’s expanding intellectual property estate, supporting the Company’s DIFS platform and ongoing clinical and regulatory initiatives
26th September, 2025
Philips’ ambulatory and diagnostic solutions and services are now available to 3.4 million Optum policyholders for enhanced outpatient cardiac monitoring
26th September, 2025
The unified brand is now ASPEN
25th September, 2025
The investment includes facility expansions, new manufacturing processes, advanced quality control systems, and implementation of new production technologies
25th September, 2025
Greenwood brings extensive leadership experience across a range of healthcare services
24th September, 2025
The voluntary action affects devices manufactured before May 12, 2025, after reports of component detachment linked to patient injuries and one death, with Olympus reinforcing safeguards to prioritise patient safety.
23rd September, 2025
The bone-sparing implant, cleared for both anatomic and reverse shoulder arthroplasty, enhances surgical flexibility and patient outcomes while reinforcing the company’s leadership in shoulder care innovation.
23rd September, 2025
The collaboration introduces BD Rowa™ Vmax robotic technology to deliver 24/7 prescription access, streamline pharmacy operations, and empower staff to focus on patient-centred care.
23rd September, 2025
The new CLIA-waived immunoassay enables simultaneous detection of influenza A/B and SARS-CoV-2 in just 10 minutes, supporting faster, cost-effective decision-making at the point of care.
23rd September, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer